Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Nov;65(11):4483–4487. doi: 10.1128/iai.65.11.4483-4487.1997

In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis.

N M Ampel 1, L Christian 1
PMCID: PMC175644  PMID: 9353023

Abstract

Using peripheral blood mononuclear cells (PBMC) from individuals with or without coccidioidal delayed-type hypersensitivity (DTH), we examined and attempted to modulate the in vitro responses of PBMC from various donors to the coccidioidal antigen toluene spherule lysate (TSL). Among healthy DTH-positive donors, 100 ng of human recombinant interleukin-10 (IL-10) per ml suppressed both PBMC proliferation (P = 0.01) and gamma interferon (IFN-gamma) and IL-12 production (for both, P < 0.05). In vitro proliferation and production of IFN-gamma and IL-12 by PBMC were significantly higher in DTH-positive donors with active coccidioidomycosis than in healthy, nonimmune controls (P < 0.05) but not in active DTH-negative donors with or without human immunodeficiency virus infection (for both, P > 0.05). Human recombinant IL-12 increased IFN-gamma production by PBMC from active, DTH-positive donors (P = 0.01) but not by PBMC from DTH-negative groups. For healthy DTH-positive donors, the median antigen-reactive cell frequency per 10(5) PBMC was 3.7, compared to 1.7 in DTH-negative donors with active coccidioidomycosis (P = 0.03). These data indicate that the in vitro TSL response is highly dependent on coccidioidal DTH. Not only do PBMC from individuals with DTH appear to respond to TSL, but their response can be modulated in vitro with either IL-10 or IL-12. On the other hand, PBMC from DTH-negative individuals do not respond in vitro to TSL and their response is not modulable, suggesting a lack of antigen response.

Full Text

The Full Text of this article is available as a PDF (381.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ampel N. M., Bejarano G. C., Salas S. D., Galgiani J. N. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults. J Infect Dis. 1992 Apr;165(4):710–715. doi: 10.1093/infdis/165.4.710. [DOI] [PubMed] [Google Scholar]
  2. Bacellar O., Brodskyn C., Guerreiro J., Barral-Netto M., Costa C. H., Coffman R. L., Johnson W. D., Carvalho E. M. Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis. 1996 Jun;173(6):1515–1518. doi: 10.1093/infdis/173.6.1515. [DOI] [PubMed] [Google Scholar]
  3. Barbee R. A., Hicks M. J. Clinical usefulness of lymphocyte transformation in patients with coccidioidomycosis. Chest. 1988 May;93(5):1003–1007. doi: 10.1378/chest.93.5.1003. [DOI] [PubMed] [Google Scholar]
  4. Brass C., Levine H. B., Stevens D. A. Stimulation and suppression of cell-mediated immunity by endosporulation antigens of Coccidioides immitis. Infect Immun. 1982 Feb;35(2):431–436. doi: 10.1128/iai.35.2.431-436.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carvalho E. M., Bacellar O., Brownell C., Regis T., Coffman R. L., Reed S. G. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol. 1994 Jun 15;152(12):5949–5956. [PubMed] [Google Scholar]
  6. Catanzaro A. Suppressor cells in coccidioidomycosis. Cell Immunol. 1981 Nov 1;64(2):235–245. doi: 10.1016/0008-8749(81)90476-7. [DOI] [PubMed] [Google Scholar]
  7. Chen L., Chen D., Block E., O'Donnell M., Kufe D. W., Clinton S. K. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J Immunol. 1997 Jul 1;159(1):351–359. [PubMed] [Google Scholar]
  8. Chougnet C., Wynn T. A., Clerici M., Landay A. L., Kessler H. A., Rusnak J., Melcher G. P., Sher A., Shearer G. M. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis. 1996 Jul;174(1):46–53. doi: 10.1093/infdis/174.1.46. [DOI] [PubMed] [Google Scholar]
  9. Corry D. B., Ampel N. M., Christian L., Locksley R. M., Galgiani J. N. Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis. J Infect Dis. 1996 Aug;174(2):440–443. doi: 10.1093/infdis/174.2.440. [DOI] [PubMed] [Google Scholar]
  10. Cox R. A., Brummer E., Lecara G. In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen. Infect Immun. 1977 Mar;15(3):751–755. doi: 10.1128/iai.15.3.751-755.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cox R. A. Immunosuppression by cell wall antigens of Coccidioides immitis. Rev Infect Dis. 1988 Jul-Aug;10 (Suppl 2):S415–S418. doi: 10.1093/cid/10.supplement_2.s415. [DOI] [PubMed] [Google Scholar]
  12. Cox R. A., Kennell W. Suppression of T-lymphocyte response by Coccidioides immitis antigen. Infect Immun. 1988 Jun;56(6):1424–1429. doi: 10.1128/iai.56.6.1424-1429.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cox R. A., Pope R. M. Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis. Infect Immun. 1987 May;55(5):1058–1062. doi: 10.1128/iai.55.5.1058-1062.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cox R. A., Vivas J. R. Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis. Cell Immunol. 1977 Jun 1;31(1):130–141. doi: 10.1016/0008-8749(77)90012-0. [DOI] [PubMed] [Google Scholar]
  15. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 1993 Sep 1;178(3):1041–1048. doi: 10.1084/jem.178.3.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Drutz D. J., Catanzaro A. Coccidioidomycosis. Part I. Am Rev Respir Dis. 1978 Mar;117(3):559–585. doi: 10.1164/arrd.1978.117.3.559. [DOI] [PubMed] [Google Scholar]
  17. Fazekas de St Groth The evaluation of limiting dilution assays. J Immunol Methods. 1982 Mar 12;49(2):R11–R23. doi: 10.1016/0022-1759(82)90269-1. [DOI] [PubMed] [Google Scholar]
  18. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991 Dec 1;147(11):3815–3822. [PubMed] [Google Scholar]
  19. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991 May 15;146(10):3444–3451. [PubMed] [Google Scholar]
  20. Fulton S. A., Johnsen J. M., Wolf S. F., Sieburth D. S., Boom W. H. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun. 1996 Jul;64(7):2523–2531. doi: 10.1128/iai.64.7.2523-2531.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gately M. K., Carvajal D. M., Connaughton S. E., Gillessen S., Warrier R. R., Kolinsky K. D., Wilkinson V. L., Dwyer C. M., Higgins G. F., Jr, Podlaski F. J. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann N Y Acad Sci. 1996 Oct 31;795:1–12. doi: 10.1111/j.1749-6632.1996.tb52650.x. [DOI] [PubMed] [Google Scholar]
  22. Gillessen S., Carvajal D., Ling P., Podlaski F. J., Stremlo D. L., Familletti P. C., Gubler U., Presky D. H., Stern A. S., Gately M. K. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol. 1995 Jan;25(1):200–206. doi: 10.1002/eji.1830250133. [DOI] [PubMed] [Google Scholar]
  23. Gong J. H., Zhang M., Modlin R. L., Linsley P. S., Iyer D., Lin Y., Barnes P. F. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun. 1996 Mar;64(3):913–918. doi: 10.1128/iai.64.3.913-918.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Graybill J. R., Stevens D. A., Galgiani J. N., Dismukes W. E., Cloud G. A. Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. Am J Med. 1990 Sep;89(3):282–290. doi: 10.1016/0002-9343(90)90339-f. [DOI] [PubMed] [Google Scholar]
  25. Harrison T. S., Levitz S. M. Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection. J Immunol. 1996 Jun 1;156(11):4492–4497. [PubMed] [Google Scholar]
  26. Harvey R. P., Stevens D. A. In vitro assays of cellular immunity in progressive coccidioidomycosis: evaluation of suppression with parasitic-phase antigen. Am Rev Respir Dis. 1981 Jun;123(6):665–669. doi: 10.1164/arrd.1981.123.6.665. [DOI] [PubMed] [Google Scholar]
  27. Landay A. L., Clerici M., Hashemi F., Kessler H., Berzofsky J. A., Shearer G. M. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. J Infect Dis. 1996 May;173(5):1085–1091. doi: 10.1093/infdis/173.5.1085. [DOI] [PubMed] [Google Scholar]
  28. Lin Y., Zhang M., Hofman F. M., Gong J., Barnes P. F. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun. 1996 Apr;64(4):1351–1356. doi: 10.1128/iai.64.4.1351-1356.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Magee D. M., Cox R. A. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun. 1996 Sep;64(9):3609–3613. doi: 10.1128/iai.64.9.3609-3613.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Magee D. M., Cox R. A. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun. 1995 Sep;63(9):3514–3519. doi: 10.1128/iai.63.9.3514-3519.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mattner F., Fischer S., Guckes S., Jin S., Kaulen H., Schmitt E., Rüde E., Germann T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol. 1993 Sep;23(9):2202–2208. doi: 10.1002/eji.1830230923. [DOI] [PubMed] [Google Scholar]
  32. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  33. Mosmann T. R., Coffman R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111–147. doi: 10.1016/s0065-2776(08)60652-5. [DOI] [PubMed] [Google Scholar]
  34. Sieling P. A., Wang X. H., Gately M. K., Oliveros J. L., McHugh T., Barnes P. F., Wolf S. F., Golkar L., Yamamura M., Yogi Y. IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol. 1994 Oct 15;153(8):3639–3647. [PubMed] [Google Scholar]
  35. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251–276. doi: 10.1146/annurev.iy.13.040195.001343. [DOI] [PubMed] [Google Scholar]
  36. Uherova P., Connick E., MaWhinney S., Schlichtemeier R., Schooley R. T., Kuritzkes D. R. In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1. J Infect Dis. 1996 Sep;174(3):483–489. doi: 10.1093/infdis/174.3.483. [DOI] [PubMed] [Google Scholar]
  37. Zhang M., Lin Y., Iyer D. V., Gong J., Abrams J. S., Barnes P. F. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun. 1995 Aug;63(8):3231–3234. doi: 10.1128/iai.63.8.3231-3234.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES